Funding
Hope.
Neurodegenerative Disease Research
funds novel research in an effort to
directly benefit patients suffering from neurodegenerative diseases.
It's time we moved the needle in ALS research.
NDR identifies promising research programs that break from tradition.
This novel research is helping to identify the causes of ALS, the phase of disease progression, and developing targeted treatments to end neurodegeneration.
Funding Novel Research
We're committed to finding a cure for ALS. That's why we work with researchers who are thinking outside-the-box to develop treatments.
Bringing Hope
NDR never loses sight of who we're fighting for: those affected by ALS. Every day, our unique approach is moving us closer to definitive treatment to extend quality of life for ALS patients.
Connecting Scientists
Our open forum allows the free exchange of information. We believe openness and transparency are the only ways we're going to beat ALS.
Identifying the Cause
NDR and our partner researchers understand that treatments are only effective if the root cause of the disorder is known. Researchers are working around the clock to identify specific biomarkers responsible for ALS.
What is ALS?
The course of ALS is death of motor neurons in 3 to 5 years, in some unusual cases 10-18 years from diagnosis. In those years the body transforms merely to skin stretched over bone; muscles disappear, limbs fail, and paralysis ensues. All the while, the mind is present and aware.
Over 5,000 people are diagnosed with amyotrophic lateral sclerosis (ALS) annually. NDR is funding novel research to bring that number to zero.
Science-based Hope
Rather than treating the symptoms of ALS, NDR and funded researchers are working toward a definitive treatment and cure for ALS.
This requires out-of-the-box thinking, 24/7 dedication, and a science-based approach to identify the cause of ALS.
Only when we get to the root cause of this disease will we actually be able to effectively treat ALS patients.
The NDR Approach
Disease Detection & Biomarker Discovery
Drug screening, repurposing, & synergy
ALS treatment clinical trials
